ZKIN stock recently completed a $5 million financing round, including a $2 million subscription at $1.58 per share, aimed at supporting growth initiatives. However, the stock has faced significant pressure, dropping 41% to $0.4820 after a 1-for-7 reverse stock split, reflecting investor concerns over dilution and financial stability. The bullish view hinges on the effective utilization of new funds to drive strategic growth, but the current price suggests skepticism about near-term recovery.